These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3780161

  • 1. Multiple-dose pharmacokinetics of piperacillin and azlocillin in 12 healthy volunteers.
    Tartaglione TA, Nye L, Vishniavsky N, Poynor W, Polk RE.
    Clin Pharm; 1986 Nov; 5(11):911-6. PubMed ID: 3780161
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of high-dose azlocillin sodium in patients with cystic fibrosis.
    Woolf RA, Koup JR, Smith AL, Hilman BC, Goldmann D, Williams-Warren J.
    Clin Pharm; 1985 Nov; 4(6):664-9. PubMed ID: 4075734
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of azlocillin in healthy subjects.
    Leroy A, Humbert G, Fillastre JP.
    Scand J Infect Dis Suppl; 1981 Nov; 29():49-54. PubMed ID: 6947405
    [Abstract] [Full Text] [Related]

  • 4. [The effect of infusion rate on pharmacokinetic parameters of azlocillin and mezlocillin].
    Haen E, Remien J, Richter E, Frank U, Adam D.
    Arzneimittelforschung; 1985 Nov; 35(5):864-8. PubMed ID: 4026911
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Overview of acylureidopenicillin pharmacokinetics.
    Bergan T.
    Scand J Infect Dis Suppl; 1981 Nov; 29():33-48. PubMed ID: 7031864
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of azlocillin in children with cystic fibrosis.
    Bergan T, Michalsen H.
    Arzneimittelforschung; 1979 Nov; 29(12a):1955-7. PubMed ID: 543899
    [Abstract] [Full Text] [Related]

  • 11. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
    Slain D, Amsden JR, Khakoo RA, Fisher MA, Lalka D, Hobbs GR.
    Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative pharmacokinetics of azlocillin and piperacillin in normal adults.
    Colaizzi PA, Polk RE, Poynor WJ, Raffalovich AC, Cefali EA, Beightol LA.
    Antimicrob Agents Chemother; 1986 May; 29(5):938-40. PubMed ID: 3729353
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
    Lim KS, Kim JR, Choi YJ, Shin KH, Kim KP, Hong JH, Cho JY, Shin HS, Yu KS, Shin SG, Kwon OH, Hwang DM, Kim JA, Jang IJ.
    Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.